---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-091422"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:18:48.047663+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences appoints Jay Goodman to Board, pivots to online gaming

## Summary
- Jay Goodman appointed as Class I director effective Oct 24, 2024; compensation $50k/yr + $15k as Comp Committee Chair.
- Blair Jordan's director offer letter terminated as he serves as Interim CEO; continues under consulting agreement.
- Goodman is son of Anthony Goodman (CEO of Elray Resources), which holds convertible preferred stock representing 40% of common.
- Company expanding into online gaming market; cites Goodman's experience in SaaS and iGaming as instrumental.
- Goodman has over 10 yrs in SaaS, 6+ yrs in iGaming, roles at Docker, Confluent, Skywind.

## SEC filing metadata
- accession: 0001213900-24-091422
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390024091422/0001213900-24-091422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390024091422/ea0218848-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-091422
- JSON: https://secwatch.observer/filing/0001213900-24-091422.json
- Plain text: https://secwatch.observer/filing/0001213900-24-091422.txt

## Key facts
- Executive change
  Jay Goodman was appointed as Director at FORUM MARKETS Inc.
  - Action: appointed
  - Role: Director
  source text: Effective October 24, 2024, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) appointed Jay Goodman (the “ Appointee ” and the “ Appointment ”) as a member of the Board of Directors (“ Board ”), which Appointment was effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024091422/0001213900-24-091422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.